Your browser doesn't support javascript.
loading
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
Schwaab, Juliana; Naumann, Nicole; Luebke, Johannes; Jawhar, Mohamad; Somervaille, Tim C P; Williams, Mark S; Frewin, Rebecca; Jost, Philipp J; Lichtenegger, Felix S; La Rosée, Paul; Storch, Nicola; Haferlach, Torsten; Horny, Hans-Peter; Fabarius, Alice; Haferlach, Claudia; Burchert, Andreas; Hofmann, Wolf-Karsten; Cross, Nicholas C P; Hochhaus, Andreas; Reiter, Andreas; Metzgeroth, Georgia.
Afiliação
  • Schwaab J; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Naumann N; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Luebke J; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Jawhar M; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Somervaille TCP; Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK.
  • Williams MS; Cancer Research UK Manchester Institute, Manchester, UK.
  • Frewin R; Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK.
  • Jost PJ; Cancer Research UK Manchester Institute, Manchester, UK.
  • Lichtenegger FS; Department of Pathology, Gloucester Royal Hospital, Gloucester, UK.
  • La Rosée P; III. Medical Department, Hematology and Oncology, Klinikum rechts der Isar, Technical University Munich, Munchen, Bayern, Germany.
  • Storch N; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.
  • Haferlach T; Klinik für Innere Medizin II, Schwarzwald-Baar-Klinikum, Villingen-Schwenningen, Germany.
  • Horny HP; Department of Hematology and Oncology, St. Vincenz Medical Centre, Limburg, Germany.
  • Fabarius A; Munich Leukemia Laboratory, Munich, Germany.
  • Haferlach C; Department of Pathology, University of Munich, Munich, Germany.
  • Burchert A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Hofmann WK; Munich Leukemia Laboratory, Munich, Germany.
  • Cross NCP; Department of Hematology, Oncology and Immunology, Philipps University Marburg, and University Medical Center Giessen and Marburg, Marburg, Germany.
  • Hochhaus A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Reiter A; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Metzgeroth G; Wessex Regional Genetics Laboratory, Salisbury, UK.
Am J Hematol ; 95(7): 824-833, 2020 07.
Article em En | MEDLINE | ID: mdl-32279331
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article